請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35699完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 許翠瑛(Tsuey-Ying Hsu) | |
| dc.contributor.author | Mei-Ling Jan | en |
| dc.contributor.author | 冉玫凌 | zh_TW |
| dc.date.accessioned | 2021-06-13T07:05:32Z | - |
| dc.date.available | 2005-08-02 | |
| dc.date.copyright | 2005-08-02 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-27 | |
| dc.identifier.citation | Adams, A. and Lindahl, T. (1975). 'Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.' Proc Natl Acad Sci U S A 72(4): 1477-81.
Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J. and Kenney, S. (2000). 'Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.' J Virol 74(3): 1224-33. Adamson, A. L. and Kenney, S. C. (1998). 'Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.' Virology 251(1): 187-97. Agostini, I., Navarro, J. M., Bouhamdan, M., Willetts, K., Rey, F., Spire, B., Vigne, R., Pomerantz, R. and Sire, J. (1999). 'The HIV-1 Vpr co-activator induces a conformational change in TFIIB.' FEBS Lett 450(3): 235-9. Agostini, I., Navarro, J. M., Rey, F., Bouhamdan, M., Spire, B., Vigne, R. and Sire, J. (1996). 'The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.' J Mol Biol 261(5): 599-606. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Seguin, C. and et al. (1984). 'DNA sequence and expression of the B95-8 Epstein-Barr virus genome.' Nature 310(5974): 207-11. Boyle, S. M., Ruvolo, V., Gupta, A. K. and Swaminathan, S. (1999). 'Association with the cellular export receptor CRM 1 mediates function and intracellular localization of Epstein-Barr virus SM protein, a regulator of gene expression.' J Virol 73(8): 6872-81. Burkitt, D. (1958). 'A sarcoma involving the jaws in African children.' Br J Surg 46(197): 218-23. Chang, L. K., Lee, Y. H., Cheng, T. S., Hong, Y. R., Lu, P. J., Wang, J. J., Wang, W. H., Kuo, C. W., Li, S. S. and Liu, S. T. (2004). 'Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.' J Biol Chem 279(37): 38803-12. Chang, P. J., Chang, Y. S. and Liu, S. T. (1998). 'Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus.' J Virol 72(6): 5128-36. Chang, P. J. and Liu, S. T. (2001). 'Function of the intercistronic region of BRLF1-BZLF1 bicistronic mRNA in translating the zta protein of Epstein-Barr virus.' J Virol 75(3): 1142-51. Chang, Y., Tung, C. H., Huang, Y. T., Lu, J., Chen, J. Y. and Tsai, C. H. (1999). 'Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.' J Virol 73(10): 8857-66. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J. and Sergeant, A. (1986). 'Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.' Embo J 5(12): 3243-9. Clough, W. (1979). 'Deoxyribonuclease activity found in Epstein--Barr virus producing lymphoblastoid cells.' Biochemistry 18(21): 4517-21. Countryman, J., Jenson, H., Seibl, R., Wolf, H. and Miller, G. (1987). 'Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.' J Virol 61(12): 3672-9. Countryman, J. and Miller, G. (1985). 'Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.' Proc Natl Acad Sci U S A 82(12): 4085-9. Cox, M. A., Leahy, J. and Hardwick, J. M. (1990). 'An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.' J Virol 64(1): 313-21. Dolyniuk, M., Pritchett, R. and Kieff, E. (1976). 'Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus.' J Virol 17(3): 935-49. Ellison, K. S., Rice, S. A., Verity, R. and Smiley, J. R. (2000). 'Processing of alpha-globin and ICP0 mRNA in cells infected with herpes simplex virus type 1 ICP27 mutants.' J Virol 74(16): 7307-19. Emami, K. H., Jain, A. and Smale, S. T. (1997). 'Mechanism of synergy between TATA and initiator: synergistic binding of TFIID following a putative TFIIA-induced isomerization.' Genes Dev 11(22): 3007-19. Epstein, M. A., Achong, B. G. and Barr, Y. M. (1964). 'Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma.' Lancet 15: 702-3. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. and Delecluse, H. J. (2000). 'The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.' Embo J 19(12): 3080-9. Given, D. and Kieff, E. (1979b). 'DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration.' J Virol 31(2): 315-24. Given, D., Yee, D., Griem, K. and Kieff, E. (1979a). 'DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA.' J Virol 30(3): 852-62. Gonzalez, R. A. and Flint, S. J. (2002). 'Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism.' J Virol 76(9): 4507-19. Graham, F. L., Smiley, J., Russell, W. C. and Nairn, R. (1977). 'Characteristics of a human cell line transformed by DNA from human adenovirus type 5.' J Gen Virol 36(1): 59-74. Gruffat, H., Duran, N., Buisson, M., Wild, F., Buckland, R. and Sergeant, A. (1992). 'Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter.' J Virol 66(1): 46-52. Gruffat, H., Manet, E., Rigolet, A. and Sergeant, A. (1990a). 'The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.' Nucleic Acids Res 18(23): 6835-43. Gruffat, H., Moreno, N. and Sergeant, A. (1990b). 'The Epstein-Barr virus (EBV) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z.' J Virol 64(6): 2810-8. Gruffat, H. and Sergeant, A. (1994). 'Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R.' Nucleic Acids Res 22(7): 1172-8. Hamm, J. and Mattaj, I. W. (1990). 'Monomethylated cap structures facilitate RNA export from the nucleus.' Cell 63(1): 109-18. Hammerschmidt, W. and Sugden, B. (1988). 'Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.' Cell 55(3): 427-33. Hampar, B., Derge, J. G., Martos, L. M. and Walker, J. L. (1971). 'Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.' Proc Natl Acad Sci U S A 68(12): 3185-9. Hardwick, J. M., Lieberman, P. M. and Hayward, S. D. (1988). 'A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.' J Virol 62(7): 2274-84. Hardwick, J. M., Tse, L., Applegren, N., Nicholas, J. and Veliuona, M. A. (1992). 'The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.' J Virol 66(9): 5500-8. Henle, G. and Henle, W. (1966). 'Studies on cell lines derived from Burkitt's lymphoma.' Trans N Y Acad Sci 29(1): 71-9. Henle, G., Henle, W. and Diehl, V. (1968). 'Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.' Proc Natl Acad Sci U S A 59(1): 94-101. Holley-Guthrie, E. A., Quinlivan, E. B., Mar, E. C. and Kenney, S. (1990). 'The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.' J Virol 64(8): 3753-9. Hung, C. H. and Liu, S. T. (1999). 'Characterization of the Epstein-Barr virus BALF2 promoter.' J Gen Virol 80 ( Pt 10): 2747-50. Izaurralde, E., Lewis, J., Gamberi, C., Jarmolowski, A., McGuigan, C. and Mattaj, I. W. (1995). 'A cap-binding protein complex mediating U snRNA export.' Nature 376(6542): 709-12. Izaurralde, E., Lewis, J., McGuigan, C., Jankowska, M., Darzynkiewicz, E. and Mattaj, I. W. (1994). 'A nuclear cap binding protein complex involved in pre-mRNA splicing.' Cell 78(4): 657-68. Izaurralde, E., Stepinski, J., Darzynkiewicz, E. and Mattaj, I. W. (1992). 'A cap binding protein that may mediate nuclear export of RNA polymerase II-transcribed RNAs.' J Cell Biol 118(6): 1287-95. Jarmolowski, A., Boelens, W. C., Izaurralde, E. and Mattaj, I. W. (1994). 'Nuclear export of different classes of RNA is mediated by specific factors.' J Cell Biol 124(5): 627-35. Kallin, B., Sternas, L., Saemundssen, A. K., Luka, J., Jornvall, H., Eriksson, B., Tao, P. Z., Nilsson, M. T. and Klein, G. (1985). 'Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells.' J Virol 54(2): 561-8. Kataoka, N., Ohno, M., Kangawa, K., Tokoro, Y. and Shimura, Y. (1994). 'Cloning of a complementary DNA encoding an 80 kilodalton nuclear cap binding protein.' Nucleic Acids Res 22(19): 3861-5. Kenney, S., Holley-Guthrie, E., Mar, E. C. and Smith, M. (1989a). 'The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators.' J Virol 63(9): 3878-83. Kieff, E. (1996). Epstein-Barr virus and it's replication. Kikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T. and et al. (1988). 'Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease.' Nature 333(6172): 455-7. Kirshner, J. R., Lukac, D. M., Chang, J. and Ganem, D. (2000). 'Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities.' J Virol 74(8): 3586-97. Klein, G., Clifford, P., Klein, E. and Stjernsward, J. (1966). 'Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction.' Proc Natl Acad Sci U S A 55(6): 1628-35. Lin, C. T., Chan, W. Y., Chen, W., Huang, H. M., Wu, H. C., Hsu, M. M., Chuang, S. M. and Wang, C. C. (1993). 'Characterization of seven newly established nasopharyngeal carcinoma cell lines.' Lab Invest 68(6): 716-27. Lindahl, T., Adams, A., Andersson-Anvret, M. and Falk, L. (1978). 'Integration of Epstein-Barr virus DNA.' IARC Sci Publ(24 Pt 1): 113-23. Littler, E. and Arrand, J. R. (1988). 'Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems.' J Virol 62(10): 3892-5. Liu, C., Sista, N. D. and Pagano, J. S. (1996). 'Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.' J Virol 70(4): 2545-55. Liu, P. and Speck, S. H. (2003). 'Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta.' Virology 310(2): 199-206. Lu, Y. L., Spearman, P. and Ratner, L. (1993). 'Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.' J Virol 67(11): 6542-50. Malik, P., Blackbourn, D. J. and Clements, J. B. (2004). 'The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor.' J Biol Chem 279(31): 33001-11. Manet, E., Allera, C., Gruffat, H., Mikaelian, I., Rigolet, A. and Sergeant, A. (1993). 'The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich region.' Gene Expr 3(1): 49-59. Manet, E., Gruffat, H., Trescol-Biemont, M. C., Moreno, N., Chambard, P., Giot, J. F. and Sergeant, A. (1989). 'Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators.' Embo J 8(6): 1819-26. Manet, E., Rigolet, A., Gruffat, H., Giot, J. F. and Sergeant, A. (1991). 'Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation.' Nucleic Acids Res 19(10): 2661-7. Marschall, M., Leser, U., Seibl, R. and Wolf, H. (1989). 'Identification of proteins encoded by Epstein-Barr virus trans-activator genes.' J Virol 63(2): 938-42. Mazza, C., Ohno, M., Segref, A., Mattaj, I. W. and Cusack, S. (2001). 'Crystal structure of the human nuclear cap binding complex.' Mol Cell 8(2): 383-96. McLauchlan, J., Phelan, A., Loney, C., Sandri-Goldin, R. M. and Clements, J. B. (1992). 'Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' processing.' J Virol 66(12): 6939-45. Miller, R. L., Glaser, R. and Rapp, F. (1977). 'Studies of an Epstein-Barr virus-induced DNA polymerase.' Virology 76(2): 494-502. Ohno, M., Kataoka, N. and Shimura, Y. (1990). 'A nuclear cap binding protein from HeLa cells.' Nucleic Acids Res 18(23): 6989-95. Phelan, A. and Clements, J. B. (1997). 'Herpes simplex virus type 1 immediate early protein IE63 shuttles between nuclear compartments and the cytoplasm.' J Gen Virol 78 ( Pt 12): 3327-31. Phelan, A., Dunlop, J. and Clements, J. B. (1996). 'Herpes simplex virus type 1 protein IE63 affects the nuclear export of virus intron-containing transcripts.' J Virol 70(8): 5255-65. Prang, N., Wolf, H. and Schwarzmann, F. (1995). 'Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.' J Virol 69(4): 2644-8. Prang, N., Wolf, H. and Schwarzmann, F. (1999). 'Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1.' J Med Virol 59(4): 512-9. Quinlivan, E. B., Holley-Guthrie, E. A., Norris, M., Gutsch, D., Bachenheimer, S. L. and Kenney, S. C. (1993). 'Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.' Nucleic Acids Res 21(14): 1999-2007. Ragoczy, T., Heston, L. and Miller, G. (1998). 'The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.' J Virol 72(10): 7978-84. Ragoczy, T. and Miller, G. (1999). 'Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.' J Virol 73(12): 9858-66. Rickinson, A. B. and Kieff, E. (1996). Epstein-Barr virus. Field's Virology. 75: 2343-2396. Ruvolo, V., Gupta, A. K. and Swaminathan, S. (2001). 'Epstein-Barr virus SM protein interacts with mRNA in vivo and mediates a gene-specific increase in cytoplasmic mRNA.' J Virol 75(13): 6033-41. Semmes, O. J., Chen, L., Sarisky, R. T., Gao, Z., Zhong, L. and Hayward, S. D. (1998). 'Mta has properties of an RNA export protein and increases cytoplasmic accumulation of Epstein-Barr virus replication gene mRNA.' J Virol 72(12): 9526-34. Shen, E. C., Henry, M. F., Weiss, V. H., Valentini, S. R., Silver, P. A. and Lee, M. S. (1998). 'Arginine methylation facilitates the nuclear export of hnRNP proteins.' Genes Dev 12(5): 679-91. Sinclair, A. J., Brimmell, M., Shanahan, F. and Farrell, P. J. (1991). 'Pathways of activation of the Epstein-Barr virus productive cycle.' J Virol 65(5): 2237-44. Sixbey, J. W., Vesterinen, E. H., Nedrud, J. G., Raab-Traub, N., Walton, L. A. and Pagano, J. S. (1983). 'Replication of Epstein-Barr virus in human epithelial cells infected in vitro.' Nature 306(5942): 480-3. Soliman, T. M., Sandri-Goldin, R. M. and Silverstein, S. J. (1997). 'Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins.' J Virol 71(12): 9188-97. Soliman, T. M. and Silverstein, S. J. (2000). 'Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways.' J Virol 74(6): 2814-25. Takada, K. and Ono, Y. (1989). 'Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.' J Virol 63(1): 445-9. Takada, K., Shimizu, N., Sakuma, S. and Ono, Y. (1986). 'trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.' J Virol 57(3): 1016-22. Tierney, R. J., Steven, N., Young, L. S. and Rickinson, A. B. (1994). 'Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.' J Virol 68(11): 7374-85. Tovey, M. G., Lenoir, G. and Begon-Lours, J. (1978). 'Activation of latent Epstein-Barr virus by antibody to human IgM.' Nature 276(5685): 270-2. Tsai, C. H., Liu, M. T., Chen, M. R., Lu, J., Yang, H. L., Chen, J. Y. and Yang, C. S. (1997). 'Characterization of Monoclonal Antibodies to the Zta and DNase Proteins of Epstein-Barr Virus.' J Biomed Sci 4(2-3): 69-77. Tsai, C. H., Williams, M. V. and Glaser, R. (1991). 'Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function.' J Virol Methods 33(1-2): 47-52. Wilson, K. F., Fortes, P., Singh, U. S., Ohno, M., Mattaj, I. W. and Cerione, R. A. (1999). 'The nuclear cap-binding complex is a novel target of growth factor receptor-coupled signal transduction.' J Biol Chem 274(7): 4166-73. Wright, D. A. and Spector, D. H. (1989). 'Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit.' J Virol 63(7): 3117-27. Yang, H., Lin, C. H., Ma, G., Orr, M., Baffi, M. O. and Wathelet, M. G. (2002). 'Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions.' Eur J Biochem 269(24): 6142-51. Yates, J., Warren, N., Reisman, D. and Sugden, B. (1984). 'A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.' Proc Natl Acad Sci U S A 81(12): 3806-10. Yates, J. L., Warren, N. and Sugden, B. (1985). 'Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.' Nature 313(6005): 812-5. Zalani, S., Holley-Guthrie, E. and Kenney, S. (1996). 'Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.' Proc Natl Acad Sci U S A 93(17): 9194-9. zur Hausen, H., O'Neill, F. J., Freese, U. K. and Hecker, E. (1978). 'Persisting oncogenic herpesvirus induced by the tumour promotor TPA.' Nature 272(5651): 373-5. 黃如慧 (2004). 尋找與EB 病毒轉活化子Rta 交互作用的細胞因子 Identification of cellular proteins that can interact with Epstein-Barr virus transactivator,Rta. 微生物學研究所 微生物及免疫學組, 國 立台灣大學醫學院. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35699 | - |
| dc.description.abstract | EB病毒的特早期基因BRLF1所表現出的轉活化子，Rta，可調控病毒由潛伏期進入溶裂期。先前Yeast two hybrid研究結果顯示，Rta與NCBP1蛋白質有交互作用。本實驗以GST沉澱法、雙向免疫沉澱法及免疫螢光染色實驗分別證實兩者之交互作用及其於細胞中位置之相關性，並以不同的NCBP1刪減片段蛋白質與GST融合的Rta蛋白質進行GST沉澱法，發現NCBP1蛋白質藉由其胺基端及羧基端與Rta蛋白質之胺基端320個胺基酸形成構形上之交互作用。進一步實驗發現NCBP1蛋白質會加強由TPA及sodium butyrate所誘發EB病毒溶裂期之進行，然而，Rta蛋白質之大量表現及溶裂期之進行並不改變細胞中NCBP1蛋白質的表現量，因此推論，或許NCBP1蛋白質之生理功能在EB病毒溶裂期進行中扮演著重要的角色。最後，觀察到NCBP1蛋白質會加強由Rta所誘發成熟的Zta mRNA表現量。 | zh_TW |
| dc.description.abstract | Abstract
Transactivator R, Rta, encoded by an EBV immediate-early gene, BRLF1, mediates the switch from latency into the lytic cycle. A yeast two hybrid study finds that Rta interacts with NCBP1 protein. In this study, GST pull-down assay, co-immunoprecipitation assay and immunofluorescent staining were performed to investigate the interaction between Rta and NCBP1 and their relative localization in cells. By using different NCBP1 deletion mutant proteins, we demonstrated that amino- and carboxyl- terminus of NCBP1 protein interacts with the amino-terminal 320 region of Rta. Additionally, NCBP1 enhances the EBV lytic gene expression which is induced by TPA and sodium butyrate. Yet, the endogenous NCBP1 protein expression remains unchanged after lytic induction. As a result, we propose that NCBP1 protein plays an important role in promoting the EBV lytic cycle progression. Finally, expression of mature Zta mRNA induced by Rta was increased under the influence of NCBP1 protein. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T07:05:32Z (GMT). No. of bitstreams: 1 ntu-94-R92445118-1.pdf: 1333053 bytes, checksum: a69cade1fe4a21c8c0014d70f9b1fa56 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | 中文摘要…………1
英文摘要…………2 序論………………3 實驗目的…………11 實驗材料…………12 實驗方法…………21 結果………………32 討論………………37 附錄………………41 參考文獻…………54 | |
| dc.language.iso | zh-TW | |
| dc.subject | Cap結合蛋白質 | zh_TW |
| dc.subject | 鼻咽癌 | zh_TW |
| dc.subject | 特早期蛋白質 | zh_TW |
| dc.subject | EB 病毒 | zh_TW |
| dc.subject | 溶裂期 | zh_TW |
| dc.subject | 基因調控 | zh_TW |
| dc.subject | Rta | en |
| dc.subject | gene regulation | en |
| dc.subject | lytic cycle | en |
| dc.subject | nuclear cap binding protein 1 | en |
| dc.subject | Epstein-Barr virus | en |
| dc.subject | transcription factor | en |
| dc.title | EB病毒轉活化子Rta與細胞因子nuclear cap binding protein 1 (NCBP1)之結合促進EB病毒特早期基因BZLF1成熟mRNA表現 | zh_TW |
| dc.title | Interaction between transactivator R (Rta) of Epstein-Barr virus and nuclear cap binding protein 1 (NCBP1) enhances mRNA expression of EB virus immediate ealy gene, BZLF1. | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 劉世東(Shih-Tung Liu),譚婉玉(Woan-Yuh Tarn) | |
| dc.subject.keyword | 鼻咽癌, 特早期蛋白質, EB 病毒, 溶裂期, 基因調控, Cap結合蛋白質, | zh_TW |
| dc.subject.keyword | Epstein-Barr virus, transcription factor, Rta, nuclear cap binding protein 1, lytic cycle, gene regulation, | en |
| dc.relation.page | 62 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-07-27 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 微生物學研究所 | zh_TW |
| 顯示於系所單位： | 微生物學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 未授權公開取用 | 1.3 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。